0.1790
-0.0288
(-13.86%)
As of 12:22:24 PM EST. Market Open.
Breakdown
TTM
5/31/2024
5/31/2023
5/31/2022
5/31/2021
Operating Cash Flow
-2,131.0000
-10,982.0000
-25,110.0000
-77,723.0000
-117,573.0000
Investing Cash Flow
--
--
--
--
-122.0000
Financing Cash Flow
16,742.0000
11,748.0000
29,927.0000
48,011.0000
137,346.0000
End Cash Position
21,335.0000
9,814.0000
9,048.0000
4,231.0000
33,943.0000
Interest Paid Supplemental Data
30.0000
45.0000
19.0000
63.0000
147.0000
Capital Expenditure
--
--
--
--
-122.0000
Issuance of Capital Stock
6,121.0000
9,137.0000
25,786.0000
41,195.0000
1,000.0000
Issuance of Debt
654.0000
2,011.0000
895.0000
--
100,000.0000
Repayment of Debt
--
--
--
--
-950.0000
Free Cash Flow
-2,131.0000
-10,982.0000
-25,110.0000
-77,723.0000
-117,695.0000
5/31/2021 - 12/13/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RLFTF Relief Therapeutics Holding SA
3.8000
-5.00%
ATHE Alterity Therapeutics Limited
4.4505
+48.85%
NWBO Northwest Biotherapeutics, Inc.
0.2690
-4.95%
VXRT Vaxart, Inc.
0.7153
-1.21%
BTAI BioXcel Therapeutics, Inc.
0.3174
-3.85%
ONCO Onconetix, Inc.
0.5706
-6.47%
SLS SELLAS Life Sciences Group, Inc.
1.2900
+5.74%
NRXP NRx Pharmaceuticals, Inc.
2.9500
-6.05%
VERU Veru Inc.
0.5788
-5.32%
CVM CEL-SCI Corporation
0.3805
-1.27%